T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2
2014 · Clinical & Experimental Metastasis · 65 citations
https://doi.org/10.1007/s10585-014-9688-8
L
Liancheng Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
1.5K
Citations
24
h-index
49
i10-index
Liancheng Zhu is an academic researcher from Xinyang Normal University. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Cancer-related molecular mechanisms research & Ferroptosis and cancer prognosis. The author has an h-index of 24, co-authored 91 publications.
ORCID: 0000-0002-0814-5816Papers by this author
worksHuman epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells
2014 · Molecular Cancer · 65 citations
https://doi.org/10.1186/1476-4598-13-243
Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
2019 · Journal of Translational Medicine · 61 citations
https://doi.org/10.1186/s12967-019-2023-z
Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway
2009 · Journal of Experimental & Clinical Cancer Research · 56 citations
https://doi.org/10.1186/1756-9966-28-154
Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells
2014 · Medical Oncology · 31 citations
https://doi.org/10.1007/s12032-014-0426-5
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
2022 · BMC Cancer · 18 citations
https://doi.org/10.1186/s12885-022-09753-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat